 8. Patient who has received radiotherapy 4 weeks or limited field radiation for palliation 2 weeks prior to starting study drug, and who has not recovered to grade 1 or better from related side effects of such therapy with the exception of alopecia andor from whom 25 R. E. Ellis 1961 of the bone marrow was irradiated. 